脂肪性肝病分类具有动态变化,影响临床试验资格及亚类特异性治疗
该前瞻性队列研究纳入1042名普通人群及脂肪性肝病(SLD)风险个体,基线与2年后按SLD命名标准分类。随访中位25个月,38%参与者SLD分类发生变化,无SLD者25%出现SLD,代谢功能障碍相关脂肪性肝病、代谢与酒精相关肝病及酒精相关肝病分别有38%、62%、69%分类改变,主要因不再符合SLD标准或酒精摄入改变。
要点
- SLD及其亚类分类在2年内高度动态,38%参与者分类改变。
- 基线代谢与酒精相关肝病和酒精相关肝病分类改变比例最高(62%和69%)。
- 分类改变主要驱动因素为不再符合SLD标准及酒精摄入变化,影响临床试验资格与临床管理。
核心结论
- SLD及其亚分类高度动态,尤其受酒精使用和肝脂肪变变化驱动,影响临床试验资格和患者临床管理。
研究设计与样本
- 前瞻性队列研究,纳入普通人群及SLD风险个体共1042例,基线和2年后按SLD命名诊断标准分类。
主要发现
- 基线时595例(57%)有SLD,其中371例(62%)为代谢功能障碍相关脂肪性肝病,140例(24%)为代谢与酒精相关肝病,83例(14%)为酒精相关肝病,1例(<1%)为隐源性SLD。
- 随访中位25个月(四分位距24-31),1042例中399例(38%)SLD分类从基线至随访发生变化。
- 基线无SLD组中25%在随访时出现SLD;基线代谢功能障碍相关脂肪性肝病组38%分类改变,代谢与酒精相关肝病组62%和酒精相关肝病组69%分类改变。
- 分类改变的主要原因为个体不再符合SLD标准或酒精摄入改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Steatotic liver disease (SLD) includes the subclasses metabolic-dysfunction-associated steatotic liver disease, metabolic and alcohol-related liver disease, and alcohol-related liver disease. We investigated the robustness of the SLD diagnoses after 2 years. METHODS: We performed a prospective cohort study among individuals from the general population and individuals at risk of SLD. Participants were classified according to the diagnostic criteria of the SLD nomenclature at baseline and after 2 years. RESULTS: We included 1042 participants, mean age was 57 ± 10 years, 663 were male (64%) and 379 (36%) female, and 70 (7%) had advanced fibrosis. At baseline, 595 (57%) had SLD, hereof 371 (62%) met the criteria for metabolic-dysfunction-associated steatotic liver disease, 140 (24%) for metabolic and alcohol-related liver disease, and 83 (14%) for alcohol-related liver disease, and 1 (<1%) was classified as cryptogenic SLD. Median time between the baseline and follow-up visit was 25 months (interquartile range, 24-31). Overall, 399 (38%) of the 1042 participants changed SLD classification from baseline to follow-up. In the group without SLD at baseline, 25% had SLD at follow-up. In comparison, 38% with metabolic-dysfunction-associated steatotic liver disease at baseline were classified differently at follow-up, whereas 62% and 69% of participants with baseline metabolic and alcohol-related liver disease and alcohol-related liver disease were classified differently at follow-up. The primary reasons for changing classification were that individuals no longer met the criteria for having SLD or had altered their alcohol intake. CONCLUSIONS: SLD and the subclassification hereof is highly dynamic, especially driven by changes in alcohol use and hepatic steatosis. This affects eligibility for clinical trials and clinical management of patients with SLD.
引用
- Israelsen M, Thorhauge KH, Andersen P, et al. Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific Treatments. Clin Gastroenterol Hepatol. 2025. PMID: 40204204. doi:10.1016/j.cgh.2025.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。